BPBT
ARIA

Boston Private Bank & Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Boston Private Bank & Trust’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,000
Closed -$34K – 1151
2014
Q4 		$34K Buy
+5,000
New +$31.3K ﹤0.01% 645

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Private Bank & Trust's ARIA Position: Q1 2015 in Review

Boston Private Bank & Trust sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2015, closing a stake of 5,000 shares — an estimated $34K sold.

Boston Private Bank & Trust first reported a position in ARIA in Q4 2014 and held it in 1 quarter. The position peaked at $34K in Q4 2014. 193 funds tracked by Wall St. Rank hold ARIA as of Q1 2015.

  • Boston Private Bank & Trust reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Boston Private Bank & Trust sold 5,000 Ariad Pharmaceuticals Inc shares in Q1 2015, an estimated $34K.
  • Boston Private Bank & Trust first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 1 quarter.
  • Boston Private Bank & Trust's Ariad Pharmaceuticals Inc position peaked at $34K in Q4 2014.
  • 193 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.